Probabilities of success for antibody therapeutics
AUTOR(ES)
Reichert, Janice M
FONTE
Landes Bioscience
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2726601Documentos Relacionados
- Success of prostaglandin E2 in structure–function is a challenge for structure-based therapeutics
- Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis.
- Laws of Large Numbers For Non-Additive Probabilities
- SUFFICIENT CONDITIONS FOR A FAMILY OF PROBABILITIES TO BE EXPONENTIAL
- Developing Therapeutics for the Treatment of Multiple Sclerosis